Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Planning surgery while taking tirzepatide demands advance communication with both your surgeon and prescribing provider. Tirzepatide, a dual GLP-1 and GIP receptor agonist, affects blood sugar control and gastric emptying—two factors that directly influence surgical risk and recovery. Understanding the timeline for stopping tirzepatide before your procedure protects your safety and helps anesthesiologists prepare appropriately.

When to Stop Tirzepatide Before Surgery

Most surgeons recommend discontinuing tirzepatide 24 to 48 hours before elective surgery, though this window varies based on procedure type, anesthesia method, and individual health factors. GIP and GLP-1 receptor agonists slow stomach emptying, which increases aspiration risk during general anesthesia—a complication that can be serious. Your surgical team must know your tirzepatide status so they can adjust fasting protocols and anesthesia induction strategies accordingly.

Emergency procedures follow different rules since there is no advance planning window. Inform the anesthesia team immediately if you have taken tirzepatide recently, even if just hours before surgery. PlexusDx recommends carrying documentation of your current tirzepatide dose and injection schedule when you arrive for any surgical consultation, allowing your care team to make fully informed decisions about timing.

Blood Sugar Control During the Surgical Window

Tirzepatide lowers blood glucose by enhancing insulin secretion and reducing glucagon release—mechanisms that become critically important when you stop the medication before surgery. Stopping tirzepatide can cause blood sugar to rise, especially in the 24 to 48 hours following your last dose. Surgical stress itself triggers glucose elevation through cortisol and adrenaline release, creating a double effect that requires monitoring.

If you have type 2 diabetes or prediabetes, your surgeon and anesthesiologist will want blood glucose readings before and after your procedure. Some patients may need temporary insulin or short-acting oral medications during the perioperative period to maintain stable glucose levels. Discuss your tirzepatide regimen openly—including the dose prescribed through PlexusDx—so your surgical team understands your baseline metabolic control.

Restarting Tirzepatide After Your Procedure

Resuming tirzepatide typically begins 3 to 7 days after surgery, once you are eating normally and surgical pain is manageable. Reintroducing a GLP-1 agonist too early risks nausea and delayed gastric emptying while your stomach is already healing from anesthesia and surgical manipulation. Your prescribing provider should communicate with your surgeon to confirm you have achieved adequate oral intake and stable vital signs before restarting.

If you were on Tirzepatide Injection from PlexusDx, coordinate the injection schedule so you don't miss your next scheduled dose by more than a few days. Most patients restart at their previous maintenance dose; dose escalation protocols resume once you have fully recovered from surgery and gastrointestinal function has normalized. Document this pause and restart sequence in your health records for future surgical planning.

Preparing for Surgery: Steps to Take Now

Schedule a preoperative consultation with your surgical team at least two weeks before your scheduled procedure. Bring a list of all medications, including your tirzepatide dose, frequency, and route (injection or oral), whether prescribed through PlexusDx or another provider. Inform your surgeon of any side effects you have experienced—nausea, vomiting, or delayed gastric emptying—as these directly inform anesthesia planning.

Contact the office where you receive tirzepatide injections or prescriptions (PlexusDx or your provider) immediately once your surgery date is confirmed. PlexusDx patients can request a medication summary that documents their current regimen, making it easy to share with surgical and anesthesia teams. Ask your prescribing provider whether you should schedule a follow-up call after surgery to confirm readiness for tirzepatide reinitiation, ensuring seamless continuity of your weight management therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long before surgery should I stop taking tirzepatide?

Most elective surgeries require stopping tirzepatide 24 to 48 hours before your procedure. This timing reduces gastric contents and aspiration risk during anesthesia. Your specific surgical and anesthesia team will confirm the exact stopping point based on your procedure type.

Will stopping tirzepatide affect my blood sugar during surgery?

Yes. Tirzepatide enhances insulin secretion and reduces glucagon, so stopping it can allow blood sugar to rise, especially when combined with surgical stress hormones. Your anesthesia team will monitor glucose levels and may use temporary insulin or other medications to maintain safe levels throughout your procedure.

What if I have an emergency surgery and recently took tirzepatide?

Tell the anesthesia team immediately how much tirzepatide you took and when. They will adjust your anesthesia induction and fasting protocols accordingly. Emergency procedures don't allow the usual 24–48 hour window, so transparency is critical for your safety.

When can I restart tirzepatide after surgery?

Most surgeons recommend waiting 3 to 7 days after your procedure, once you are eating solid foods and pain is controlled. Restarting too early increases nausea and delayed stomach emptying while you're still healing. Coordinate with your prescribing provider and surgeon before restarting to confirm you are ready.

Does PlexusDx offer any special support for surgical patients?

PlexusDx patients can request a medication summary documenting their tirzepatide dose and regimen to share with their surgical team. Your provider can also schedule a post-surgery call to confirm you are ready to reinitiate treatment. If you have genetic predispositions identified by the Precision Peptide Genetic Test, sharing those insights with your surgical team may inform additional perioperative planning.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves